Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant c-MET antibody

The Rabbit Monoclonal anti-c-MET antibody has been validated for WB, ELISA, IHC, IF and FACS. It is suitable to detect c-MET in samples from Human.
Catalog No. ABIN7127616

Quick Overview for Recombinant c-MET antibody (ABIN7127616)

Target

See all c-MET (MET) Antibodies
c-MET (MET) (Met Proto-Oncogene (MET))

Antibody Type

Recombinant Antibody

Reactivity

  • 231
  • 130
  • 98
  • 6
  • 5
  • 5
  • 5
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 201
  • 40
  • 4
  • 3
  • 2
Rabbit

Clonality

  • 190
  • 56
  • 2
Monoclonal

Conjugate

  • 135
  • 19
  • 10
  • 10
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 5
  • 5
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
This c-MET antibody is un-conjugated

Application

  • 160
  • 100
  • 45
  • 32
  • 32
  • 20
  • 15
  • 14
  • 14
  • 10
  • 8
  • 5
  • 4
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF), Flow Cytometry (FACS)

Clone

2D12
  • Cross-Reactivity

    Human

    Purification

    Affinity-chromatography

    Immunogen

    A synthesized peptide derived from human Met (c-Met)

    Isotype

    IgG
  • Application Notes

    Recommended dilution: WB:1:500-1:5000, IHC:1:50-1:200, IF:1:20-1:200, FC:1:20-1:200,

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C,-80 °C

    Storage Comment

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    c-MET (MET) (Met Proto-Oncogene (MET))

    Alternative Name

    MET

    Background

    Background: Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to hepatocyte growth factor/HGF ligand. Regulates many physiological processes including proliferation, scattering, morphogenesis and survival. Ligand binding at the cell surface induces autophosphorylation of MET on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with the PI3-kinase subunit PIK3R1, PLCG1, SRC, GRB2, STAT3 or the adapter GAB1. Recruitment of these downstream effectors by MET leads to the activation of several signaling cascades including the RAS-ERK, PI3 kinase-AKT, or PLCgamma-PKC. The RAS-ERK activation is associated with the morphogenetic effects while PI3K/AKT coordinates prosurvival effects. During embryonic development, MET signaling plays a role in gastrulation, development and migration of muscles and neuronal precursors, angiogenesis and kidney formation. In adults, participates in wound healing as well as organ regeneration and tissue remodeling. Promotes also differentiation and proliferation of hematopoietic cells. May regulate cortical bone osteogenesis (By similarity).

    Aliases: Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met), MET

    UniProt

    P08581

    Pathways

    RTK Signaling, Carbohydrate Homeostasis, Synaptic Membrane, Signaling of Hepatocyte Growth Factor Receptor
You are here:
Chat with us!